- Colorectal cancer has started to spread to other parts of the body
- Gastrointestinal stromal tumours (GIST) (a type of stomach and bowel cancer)
- Liver cancer in adult patients who have already undergone treatment with Sorafenib (anticancer medicine)
Sale!
Regolieva 40mg
REGORAFENIB TABLETS 40MG
| MRP | : |
|
| Price | : | ₹5,100.00 |
| You Save | : | ₹4,181.25 (45.05%) |
28 Tablet(s) In A Bottle
Regolieva 40mg Tablet is a specialized treatment that includes the active ingredient regorafenib. It is indicated for the management of colon cancer, rectal cancer, liver cancer, and gastrointestinal stromal tumors (GIST), which are types of cancers affecting the stomach and intestines. Cancer is characterized by the uncontrolled and abnormal proliferation of cells.
Consult your physician if you have any liver issues, infections, bleeding disorders, gastrointestinal problems, chest pain, heart conditions, hypertension, chronic headaches, or seizures, or if you have recently undergone or are planning to undergo surgery before starting this medication. Regolieva 40mg Tablet is not advised for use in adolescents and children.
Refrain from consuming grapefruit juice while on this medication, as it may interfere with its effectiveness. Employ reliable birth control methods during treatment and for at least eight weeks following the final dose. If you are following a salt-restricted diet, discuss this with your doctor, as Regolieva 40mg Tablet contains sodium.
